Moderna
MRNA
#1544
Rank
A$20.46 B
Marketcap
A$52.38
Share price
3.25%
Change (1 day)
-17.27%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: A$20.46 Billion

As of December 2025 Moderna has a market cap of A$20.46 Billion. This makes Moderna the world's 1544th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025A$20.46 B-17.57%
2024A$24.82 B-55.39%
2023A$55.65 B-45.11%
2022A$101.40 B-28.61%
2021A$142.03 B164.2%
2020A$53.76 B471.83%
2019A$9.40 B31.92%
2018A$7.12 B

End of Day market cap according to different sources

On Dec 22nd, 2025 the market cap of Moderna was reported to be:

A$20.46 Billion
by Nasdaq info icon info icon
A$20.46 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regulus Therapeutics
RGLS
A$0.84 B-95.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$392.56 B 1,818.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
A$1.25 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$80.84 B 295.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$394.14 B 1,825.88%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
A$14.31 B-30.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$749.64 B 3,562.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
A$4.46 B-78.16%๐Ÿ‡บ๐Ÿ‡ธ USA